Holen Sie sich die Stockscreener-App
20.80
5.80%
-1.28
Handel nachbörslich:
20.80
Schlusskurs vom Vortag:
$22.08
Offen:
$22.09
24-Stunden-Volumen:
118.44K
Relative Volume:
0.52
Marktkapitalisierung:
$343.73M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-17.46%
1M Leistung:
-28.13%
6M Leistung:
-66.24%
1J Leistung:
+0.00%
1-Tages-Spanne:
$20.42
$22.12
1-Wochen-Bereich:
$20.42
$27.16
52-Wochen-Spanne:
$16.38
$74.07
Claritev Corp Stock (CTEV) Company Profile
Firmenname
Claritev Corp
Sektor
Branche
Telefon
212-780-2000
Adresse
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
20.80 | 364.89M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
177.04 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.61 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.06 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.96 | 5.03B | 550.17M | 201.35M | 232.07M | 1.00 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-12 | Eingeleitet | Guggenheim | Buy |
| 2026-01-09 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-10-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Neutral |
| 2022-12-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-07-12 | Eingeleitet | Goldman | Neutral |
| 2021-10-04 | Fortgesetzt | Citigroup | Buy |
| 2021-04-07 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-19 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Claritev Corp Aktie (CTEV) Neueste Nachrichten
Claritev’s Strategic Pivot: A Critical Juncture for the Former MultiPlan - AD HOC NEWS
What Catalysts Are Shifting The Claritev (CTEV) Narrative Now - Yahoo Finance
RSI Check: Can Claritev Corporation weather a recessionQuarterly Profit Review & Long-Term Safe Return Strategies - baoquankhu1.vn
Ideas Watch: Is Claritev Corporation part of any ETFChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
Swing Trade: What is the earnings history of Claritev Corporation2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
IPO Launch: What are analysts price targets for Claritev CorporationWeekly Loss Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Aug Weekly: What is the next catalyst for Claritev Corporation2025 Top Decliners & Comprehensive Market Scan Insights - baoquankhu1.vn
CTEVClaritev Corp Latest Stock News & Market Updates - Stock Titan
Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call - Business Wire
AustralianSuper Pty Ltd Buys Shares of 3,195,270 Claritev $CTEV - MarketBeat
Analyst Calls: Will Claritev Corporation benefit from seasonalityWeekly Stock Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Claritev partners with Kinetiq Health to tackle high-cost healthcare claims - Investing.com Australia
Claritev (CTEV) Enters Strategic Partnership with Kinetiq Health - GuruFocus
Claritev and Kinetiq Health Enter Into Strategic Agreement to Strengthen Cost Management and Advance Claims Surveillance and Diagnostic Certainty - marketscreener.com
Claritev : and Kinetiq Health enter into strategic agreement to strengthen cost management and advance claims surveillance and diagnostic certainty - marketscreener.com
Claritev Corporation (NYSE:CTEV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st
Claritev Corporation (CTEV) Stock Analysis: A Closer Look At The 90.45% Potential Upside - DirectorsTalk Interviews
Lobbying Update: $150,000 of CLARITEV (FORMERLY MULTIPLAN CORPORATION) lobbying was just disclosed - Quiver Quantitative
CTEV: Transformation, tech investment, and client focus drive growth and innovation in healthcare - TradingView
Claritev outlines long-term growth strategy at healthcare conference - TipRanks
Claritev Corp Releases Investor Presentation at Healthcare Conference - TradingView
Claritev (NYSE:CTEV) Shares Gap DownHere's Why - MarketBeat
Claritev: The Middleman In A Vertically Integrated Market (NYSE:CTEV) - Seeking Alpha
Claritev (CTEV) Price Target Decreased by 26.64% to 66.10 - Nasdaq
Aug Volume: What is Claritev Corporations P E ratio telling us2025 Macro Impact & Verified Short-Term Trading Plans - baoquankhu1.vn
Chipmakers Recap: How Claritev Corporation stock reacts to bond yieldsJuly 2025 Macro Moves & Consistent Return Investment Signals - Bộ Nội Vụ
Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target - marketscreener.com
Guggenheim initiates coverage on Claritev stock with Buy rating By Investing.com - Investing.com UK
Guggenheim initiates coverage on Claritev stock with Buy rating - Investing.com
175,767 Options of Claritev Corporation are subject to a Lock-Up Agreement Ending on 12-JAN-2026. - marketscreener.com
Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates - MSN
Claritev announces pricing of 1.5 million share secondary offering at $51.50 a piece - MSN
Why Claritev Corporation stock could rally in 20252025 Volatility Report & Daily Stock Trend Reports - Улправда
Does Claritev Corporation stock trade at a discount to peersTrend Reversal & AI Forecasted Entry/Exit Points - Улправда
Wells Fargo Initiates Coverage of Claritev (CTEV) with Equal-Weight Recommendation - Nasdaq
Claritev (CTEV): Citigroup Lowers Price Target while Maintaining Buy Rating | CTEV Stock News - GuruFocus
Wells Fargo initiates Claritev stock with Equal Weight rating, $33 target - Investing.com Nigeria
Wells Fargo Initiates Coverage on CTEV with Equal-Weight Rating - GuruFocus
Wells Fargo initiates Claritev stock with Equal Weight rating, $33 target By Investing.com - Investing.com South Africa
Claritev price target lowered to $63 from $80 at Citi - TipRanks
What Catalysts Are Reshaping The Claritev (CTEV) Narrative On Growth Versus Leverage Risks - Yahoo Finance
Claritev Corporation Class A Common Stock (NY: CTEV - FinancialContent
Why Claritev Corporation Class stock stays resilientMarket Activity Summary & Reliable Price Breakout Alerts - ulpravda.ru
Can Claritev Corporation stock withstand economic slowdownJuly 2025 PostEarnings & Stepwise Trade Signal Guides - ulpravda.ru
Claritev initiated with an Equal Weight at Wells Fargo - TipRanks
Why Claritev Corporation stock remains a top recommendationJuly 2025 Analyst Calls & Weekly High Conviction Ideas - Улправда
Sentiment Review: Does Claritev Corporation stock trade at a discount to peersIPO Watch & Fast Entry High Yield Tips - Улправда
Can Claritev Corporation stock weather global recessionJuly 2025 Trade Ideas & Growth Oriented Trading Recommendations - Улправда
Star TribuneClaritev Corporation Class A Common Stock (NYSE:CTEV) Stock Quote - FinancialContent
Claritev Corporation to Present at J.P. Morgan Healthcare Conference - 01net
Finanzdaten der Claritev Corp-Aktie (CTEV)
Es liegen keine Finanzdaten für Claritev Corp (CTEV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):